ClearSign Technologies Corporation Announces Changes to Board of Directors
MWN-AI** Summary
ClearSign Technologies Corporation (Nasdaq: CLIR), a company focused on industrial combustion and sensing technologies aimed at decarbonization and improved energy efficiency, announced significant changes to its Board of Directors on May 27, 2025. The Board has expanded its size from five to seven members, appointing Anthony DiGiandomenico and Lou Basenese to fill the newly created seats, effective May 22, 2025.
Anthony DiGiandomenico, with extensive experience in disruptive technologies, currently serves as Chief of Transactions and director at MDB Capital Holdings, having co-founded the firm in 1997. His background includes advising various companies in biotechnology, medical devices, and renewable energy. He has also held board positions in notable organizations such as Provention Bio, Inc., and Cue Biopharma, Inc.
Lou Basenese brings over 25 years of expertise in equity research, investment banking, and strategic planning. He is currently the Executive Vice President for Market Strategy at Prairie Operating Co. and leads The Basenese Group, a full-service equity research and advisory firm. Basenese holds positions on the boards of ENDRA Life Sciences, Inc., and The Roberto Clemente Health Clinic, contributing to healthcare initiatives in Nicaragua.
Additionally, current Board member David M. Maley announced he would not seek re-election at the upcoming annual meeting in 2025. ClearSign CEO Jim Deller expressed enthusiasm for the new board members, citing their familiarity with the company and their valuable industry connections.
ClearSign Technologies designs products aimed at improving operational performance and safety while significantly reducing emissions, contributing to a more sustainable energy future. Their innovations, such as ClearSign Core™ and ClearSign Eye™, enhance combustion and safety systems across various sectors, including energy, chemicals, and power industries. For further information, visit their website at www.clearsign.com.
MWN-AI** Analysis
In light of ClearSign Technologies Corporation’s recent announcement regarding its Board of Directors, market observers should assess the implications of these changes for investment strategies moving forward. The expansion of the Board from five to seven directors, particularly with the addition of Anthony DiGiandomenico and Lou Basenese, signals a strategic effort to enhance leadership capabilities in navigating the competitive landscape of industrial combustion and sensing technologies, especially as the industry shifts toward decarbonization.
DiGiandomenico's extensive experience in funding disruptive technologies, particularly in renewable energy sectors, bodes well for ClearSign as it seeks to capitalize on trends for cleaner fuels and operations. His background suggests a potential for innovative partnerships and funding opportunities that could accelerate ClearSign’s growth trajectory. Similarly, Basenese’s experience in equity research and market strategy may bolster investor confidence and enhance market communications, crucial for a company in a growth phase.
However, it is noteworthy that David M. Maley will not seek re-election, which creates uncertainty regarding continuity and strategy. Investors should monitor any announcements regarding Maley's replacement closely, as the decision could affect ClearSign's future direction and operational stability.
From a market perspective, it may be wise to adopt a wait-and-see approach regarding ClearSign Technologies. Given the company's focus on decarbonization, there is significant long-term potential, particularly as industries seek to comply with stricter environmental regulations. Nonetheless, the market may initially react cautiously due to leadership changes. Market participants would be prudent to evaluate performance metrics and strategic updates in the coming quarters before fully committing to a position, balancing potential growth against inherent risks associated with leadership transitions.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
PR Newswire
TULSA, Okla. , May 27, 2025 /PRNewswire/ -- ClearSign Technologies Corporation (Nasdaq: CLIR) ("ClearSign" or the "Company"), an emerging leader in industrial combustion and sensing technologies that support decarbonization , improve operational and energy efficiency, enable the use of hydrogen as a fuel and enhance safety while dramatically reducing emissions, today announced that the Company's Board of Directors (the "Board") has voted to expand in size from five to seven directors and it appointed Anthony DiGiandomenico and Lou Basenese to fill such newly created vacancies and to serve as members of the Board, effective as of May 22, 2025. Further, on May 27, 2025 , David M. Maley , a member of the Board, notified the Company that he will not stand for re-election upon the expiration of his term at the Company's 2025 annual meeting of stockholders. The Board has not yet determined whether it will reduce its size or nominate a replacement director at this time.
"I am very pleased to welcome both Anthony and Lou to the Board," said Jim Deller , Ph.D., Chief Executive Officer of ClearSign. "Both have been long time supporters of ClearSign. Their existing knowledge of the Company and its technologies combined with their capital markets experience and industry connections will make them valuable and productive additions to the Board. Additionally, David Maley has indicated that he will not be standing for re-election on the upcoming annual meeting of stockholders, and we thank him for his service to ClearSign."
Mr. DiGiandomenico has been working with and enabling investment into early-stage disruptive technologies for most of his career. He has worked alongside a wide range of companies in biotechnology, medical devices, high technology, and renewable energy spaces. Mr. DiGiandomenico currently serves as the Chief of Transactions and director of MDB Capital Holdings, LLC (NASDAQ: MDBH), a broker-dealer and financial advisory firm based in Dallas, Texas , which he co-founded in 1997 as MDB Capital Group, LLC. Previously, he has served on the board of directors of Provention Bio, Inc., a developer of multiple drug therapies, from January 2017 until May 2020 and the board of directors of Cue Biopharma, Inc., a company that develops novel biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders, from January 2016 to October 2019 . Mr. DiGiandomenico holds an MBA from the Haas School of Business at the University of California, Berkeley and a B.S. in Finance from the University of Colorado .
Lou Basenese brings over 25 years of experience in equity research and analysis, investment banking, strategic planning, thought leadership development and communications. Mr. Basenese currently serves as Executive Vice President – Market Strategy for Prairie Operating Co. (Nasdaq: PROP), a Houston -based publicly traded independent energy company engaged in the development and acquisition of oil and natural gas resources in the United States . He also serves as CEO and Chief Strategist of The Basenese Group, LLC, a full-service equity research, strategy, and advisory firm. Mr. Basenese also serves on the board of directors of ENDRA Life Sciences, Inc., a life sciences company that develops technologies to improve the capabilities of clinical diagnostic ultrasound, and the board of directors of The Roberto Clemente Health Clinic, a U.S.-based non-profit that provides affordable access to high quality health care and wellness programs in the Tola coastal communities of Nicaragua . Prior to his current roles, Mr. Basenese served as President and Chief Market Strategist of MDB Capital Holdings, LLC and in various analyst, strategist, and account executive roles in the financial services and research industries. Mr. Basenese holds an MBA from the Crummer Graduate School of Business at Rollins College and a B.A. in English from the University of Florida .
About ClearSign Technologies Corporation
ClearSign Technologies Corporation designs and develops products and technologies for the purpose of decarbonization and improving key performance characteristics of industrial and commercial systems, including operational performance, energy efficiency, emission reduction, safety, the use of hydrogen as a fuel and overall cost-effectiveness. Our patented technologies, embedded in established OEM products as ClearSign Core™ and ClearSign Eye™ and other sensing configurations, enhance the performance of combustion systems and fuel safety systems in a broad range of markets, including the energy (upstream oil production and down-stream refining), commercial/industrial boiler, chemical, petrochemical, transport and power industries. For more information, please visit www.clearsign.com .
SOURCE ClearSign Technologies Corporation
FAQ**
How do the appointments of Anthony DiGiandomenico and Lou Basenese to the Board from MDB Capital Holdings LLC (MDBH) influence ClearSign Technologies’ strategic direction in decarbonization and industrial efficiency?
What specific contributions are expected from new Board members with their extensive backgrounds in equity research and investment, particularly from MDB Capital Holdings LLC (MDBH)?
Considering David M. Maley’s decision not to seek re-election, how does ClearSign plan to address any potential gaps in expertise, especially given the experience from MDB Capital Holdings LLC (MDBH)?
How might the Board's expansion to seven directors impact ClearSign's growth strategy, especially regarding partnerships in the energy sector, including affiliations with MDB Capital Holdings LLC (MDBH)?
**MWN-AI FAQ is based on asking OpenAI questions about ClearSign Technologies Corporation (NASDAQ: CLIR).
NASDAQ: CLIR
CLIR Trading
-1.32% G/L:
$0.5459 Last:
2,701 Volume:
$0.5361 Open:
